Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk
2021; American Medical Association; Volume: 6; Issue: 8 Linguagem: Inglês
10.1001/jamacardio.2021.1157
ISSN2380-6591
AutoresSteven E. Nissen, A. Michael Lincoff, Kathy Wolski, Christie M. Ballantyne, John J.P. Kastelein, Paul M. Ridker, Kausik K. Ray, Darren K. McGuire, Dariush Mozaffarian, Wolfgang Köenig, Michael H. Davidson, Michelle Garcia, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Matthew Poole, Venu Menon, Stephen J. Nicholls,
Tópico(s)Natural Products and Biological Research
ResumoIn patients treated with ω-3 fatty acids, it remains uncertain whether achieved levels of eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) are associated with cardiovascular outcomes.
Referência(s)